Clinical Trial Update: Intermediate Size Expanded Access Protocol for the Treatment of Post-COVID-19 Syndrome

View source ↗

Summary

This update describes an intermediate-size expanded access protocol for post-COVID-19 syndrome. The protocol, sponsored by Hope Biosciences Research Foundation,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-acute Sequelae of Sars-cov-2 Infection

Snippet

Sponsor: Hope Biosciences Research Foundation | Conditions: Post COVID-19 Syndrome | Status: NO_LONGER_AVAILABLE